Will develop new clinical trials, expand specialty care access for patients.
The first dedicated breast coil was introduced more than 30 years ago. Since that time, breast MR has proven its value as a breast imaging modality.
ARRT honors three in I Am the Gold Standard program
Here's what to expect for the show in February.
Company gets quarter million dollar grant to test breast cancer therapy device.
Incorporates plastic scintillation detectors developed by Medscint
Digisens launches NITRO® its new module to create reconstructions using a very limited number of projections. This new module will enable DIGISENS to provide the medical and research fields with a means of reducing radiation doses from factor 6 to 8 both for scanners and electron microscopes. Combined with its DigiXCT and DigiECT software, this module completes its offering for the tomographic world.
Ultrahigh-powered magnets, a new gold standard in radiotherapy and the Chuck Norris effect on gadolinium
Reduces radiation exposure by up to 84%
First facility associated with a Comprehensive Cancer Center, fourth in the country, to offer advanced beam therapy. Treatment is costly but promising.
Program emphasizes imaging informatics strategies for developing best practices
As one of the largest health systems in the world, Henry Ford remains at the leading edge of medical education.
Applies to cancer that has spread to specific mediastinal lymph nodes.
Researchers get $12.7 million NIH grant.
70 percent reduction in cancer cells
Compelling evidence for ViewRay MRIdian linac presented at ASTRO
Bringing greater expertise to smaller cyclotron technology
Federal officials fund the development of six anti-radiation drugs.
A few of the must-visit companies exhibiting at ECR 2019
Will install Ethos system with HyperSight imaging as part of deal
Company also shows portfolio of information management solutions.
The state's first proton therapy center will treat about 1,500 patients annually.
Initiative to focus on three types of imaging procedures with high radiation doses.
Acceletronics Digital Imaging, LLC announces it has received 510(K) marketing clearance from the US Food and Drug Administration (FDA) for the new RAD II KV Imager for Image Guided Radiation Therapy (IGRT). The RAD II KV Imager can be mounted on virtually any model of linear accelerator.
Bringing AI to a difficult cancer